---
layout: post
title: "泽璟制药：ZG005粉针剂临床试验获FDA批准"
date: 2022-01-20 16:16:53 +0800
categories: emnews
tags: 东财滚动新闻
---
> 泽璟制药公告，ZG005粉针剂临床试验申请获得FDA批准，用于治疗实体瘤患者。（财联社）

<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.688266" data-code="688266|1|1" data-code2="688266|1|23|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.688266&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 688266_0" data-code="K 688266|1|1" data-code2="K 688266|1|23|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>泽璟制药<span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，ZG005粉针剂临床试验申请获得FDA批准，用于治疗实体瘤患者。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1354,202201202255171530.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)